Category Archives: Price hikes

Time to put a stop to the abuse of orphan drug regulation- the latest scandal

10th Jan 2019, New Delhi Source: Medicines Law and Policy Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch Erasmus medical centre in Rotterdam. For … Continue reading

Posted in Access to Medecines, Cancer, Innovation, orphan drug, Patent, Price hikes, Pricing | Leave a comment

KHN launches “Pre$cription for Power,” a groundbreaking database to expose Big Pharma’s ties to patient groups.

Source: Kaiser Health News Pharmaceutical companies gave at least $116 million to patient advocacy groups in a single year, reveals a new database logging 12,000 donations from large publicly traded drugmakers to such organizations. Even as these patient groups grow in number … Continue reading

Posted in Bad Pharma, Big Pharma myths, Drug prices, Price hikes, Price Negotiations, Uncategorized | Leave a comment

Cancer Drug Price Rises 1, 400% With No Generic to Challenge It

By Peter Loftus, Wall Street Journal Since 2013, the price of a 40-year-old, off-patent cancer drug in the U.S. has risen 1,400%, putting the life-extending medicine out of reach for some patients. Introduced in 1976 to treat brain tumors and Hodgkin … Continue reading

Posted in Cancer, Drug prices, Generics, Price hikes, Uncategorized | Leave a comment

Epipen Price Gouging

People in the US continue to battle with high drug prices and the recent controversy around Epipen (Epinephrine injections) is another example that has drawn attention to the escalating drug prices. Anaphylaxis is a serious life-threatening allergic reaction, which in … Continue reading

Posted in Drug prices, Price hikes, Uncategorized | Leave a comment

France gets G7 to discuss global regulation of medicine prices

By Matthias Blamont & Jean- Baptiste Vey, Reuters | May 3, 2016 France will press its G7 partners this month to launch an “irreversible” process to control the prices of new medicines, part of a global drive to make life-saving … Continue reading

Posted in Price hikes, Pricing, Uncategorized | Leave a comment

Canadian pharma group raises price of NHS eye drug 14-fold

By Dan McCrum in London and David Crow, Financial Times, New York| May 1, 2016 The National Health Service has been stung by a Canadian drugs group that has heavily increased the prices of some generic medicines in a move … Continue reading

Posted in Price hikes, Uncategorized | Leave a comment

Petition by civil society to President Hollande on exorbitant prices of cancer drugs & demands transparency in pricing of innovative drugs

To fight the soaring prices of cancer medicines globally, French Cancer League last week initiated a petition to reiterates the following issues: Prices of cancer treatments are “unjustified, illegitimate, unacceptable & unsustainable” for the French public health system Medicines should … Continue reading

Posted in Innovation, Petitions, Price hikes, Transparency, Uncategorized | Leave a comment